Frontlight ResearchEarly access
Trial site
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer4 trials
- Childhood cancers3 trials
- Lung cancer3 trials
- Hodgkin lymphoma2 trials
- Melanoma2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- and 11 more
- Phase
- Phase 38 trials
- Phase 1/24 trials
- Phase 13 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting4 trials
- Lead sponsor
- Bristol-Myers Squibb2 trials
- Pfizer2 trials
- Aptose Biosciences Inc.1 trial
- Arcus Biosciences, Inc.1 trial
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Neuroblastoma1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Completed
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
Recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026